+Compare
CRON
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
825.61M

CRON Price Prediction, Cronos Group AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for CRON with price predictions
08:00 PM EDT Sep 26, 2023

CRON sees MACD Histogram crosses below signal line

CRON saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 21, 2023. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CRON moved out of overbought territory on September 15, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 22, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on CRON as a result. In of 112 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRON declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRON broke above its upper Bollinger Band on September 11, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

CRON moved above its 50-day moving average on August 30, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CRON crossed bullishly above the 50-day moving average on September 07, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRON advanced for three days, in of 222 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 112 cases where CRON Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.692) is normal, around the industry mean (85.806). P/E Ratio (0.000) is within average values for comparable stocks, (58.591). CRON's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.373). CRON has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (9.124) is also within normal values, averaging (61.742).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I. Advisor
published Earnings

CRON is expected to report earnings to rise 140.00% to -2 cents per share on November 14

Cronos Group CRON Stock Earnings Reports
Q3'23
Est.
$-0.02
Q2'23
Beat
by $0.02
Q1'23
Missed
by $0.01
Q4'22
Missed
by $0.16
Q3'22
Missed
by $0.04
The last earnings report on August 08 showed earnings per share of 0 cents, beating the estimate of -2 cents. With 2.43M shares outstanding, the current market capitalization sits at 825.61M.
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.59B. The market cap for tickers in the group ranges from 246 to 81.81B. ZTS holds the highest valuation in this group at 81.81B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -1%. For the same Industry, the average monthly price growth was 44%, and the average quarterly price growth was 12%. CHHE experienced the highest price growth at 121%, while NEPT experienced the biggest fall at -66%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was 10%. For the same stocks of the Industry, the average monthly volume growth was 143% and the average quarterly volume growth was 113%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 71
Price Growth Rating: 57
SMR Rating: 85
Profit Risk Rating: 92
Seasonality Score: -14 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

pharmaceutical, medical marijuana, cannabis

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
111 Peter Street
Phone
+1 416 504-0004
Employees
447
Web
https://www.thecronosgroup.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARYVX11.020.08
+0.73%
American Century Global Real Estate Inv
JNMCX14.800.09
+0.61%
Janus Henderson Mid Cap Value D
SUSSX11.850.07
+0.59%
State Street Instl US Equity Svc
RCLIX32.180.17
+0.53%
T. Rowe Price US Large-Cap Core I
PGLOX13.790.06
+0.44%
T. Rowe Price Global Consumer

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-2.42%
SNDL - CRON
73%
Closely correlated
-2.54%
TLRY - CRON
68%
Closely correlated
-2.08%
OGI - CRON
65%
Loosely correlated
-2.99%
CGC - CRON
62%
Loosely correlated
-8.58%
ACB - CRON
55%
Loosely correlated
-10.57%
More